As Core PCR Patents Expire March 28, Stratagene Crafts Molecular Dx Strategy | GenomeWeb

Stratagene CEO Joe Sorge circled the date — March 28, 2005 — in the company's fourth-quarter conference call last week.

"This will mark the beginning of an opportunity for us to move into the molecular diagnostics market," Sorge said.

Why March 28? On that date, Roche's core PCR patents will expire, and Sorge, like others in the molecular biology tools market, is preparing to be freed from the patent barriers that kept his company from using the technology more broadly.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.